Sign in

CIK 0001689548

  • Large accelerated filer

Praxis Precision Medicines, Inc.

Sign in to watch
Ticker
PRAX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-300-8460
Business address
99 HIGH STREET, 30TH FLOOR, BOSTON, MA, 02110
  1. 3 Insider Initial Statement of Ownership
  2. 4 Grant or award Chief Commercial Officer acquired 16,800 shares (grant or award)
  3. 4 Grant or award General Counsel and Secretary acquired 12,400 shares (grant or award)
  4. 4 Grant or award Principal Accounting Officer acquired 8,200 shares (grant or award)
  5. 4 Grant or award Chief Executive Officer acquired 52,800 shares (grant or award)
  6. 4 Grant or award Chief Medical Officer acquired 24,512 shares (grant or award)
  7. 4/A Open-market buy Director bought 250,000 shares at $19.00 ($4,750,000)
  8. 4 Exercise or conversion Chief Medical Officer acquired 45,000 shares (option exercise)
  9. 4 Open-market buy Chief Executive Officer bought 3,846 shares at $26.08 ($100,304)
  10. 4 Exercise or conversion Principal Accounting Officer acquired 12,218 shares (option exercise)
  11. 4 Conversion 10% owner acquired 7,800,553 shares (conversion)
  12. 4 Conversion 10% owner acquired 7,800,553 shares (conversion)
  13. 4 Conversion 10% owner acquired 2,442,080 shares (conversion)
  14. 4 Conversion Chief Executive Officer acquired 20,604 shares (conversion)
  15. 4 Conversion Director acquired 2,689,329 shares (conversion)
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 10 of 11 · 210 filings